Market
Temasek sells Celltrion stake in block deal
April 2, 2020
Ion Investments, an affiliate of Singaporean investment firm Temasek Holdings, sold millions of shares of Korean biosimilar giant Celltrion and its distribution affiliate Celltrion Healthcare in a block deal before markets opened, according to news reports Thursday. The Singapore-based investment firm sold 2.57 million shares, or 1.9 percent, of Celltrion, and 2.21 million shares, or 1.5 percent, of Celltrion Healthcare via the block trading deal. The stock price of Celltrion fell 8.08 perc